Abivax SA American Depositary Shares (ABVX)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Abivax SA American Depositary Shares, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Abivax SA American Depositary Shares (ABVX) returned -6.42% year-to-date (YTD) and -52.03% over the past 12 months.

The table below presents the monthly returns of ABVX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.

The current rank of ABVX is 7, meaning it’s performing worse than 93% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.

The charts below present risk-adjusted performance metrics for Abivax SA American Depositary Shares (ABVX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Abivax SA American Depositary Shares Sharpe ratios as of May 9, 2025 (values are recalculated daily):

• 1-Year: -0.95
• All Time: -0.22

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Abivax SA American Depositary Shares compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Abivax SA American Depositary Shares. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Abivax SA American Depositary Shares was 67.46%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Abivax SA American Depositary Shares drawdown is 56.89%.

The current Abivax SA American Depositary Shares volatility is 19.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Abivax SA American Depositary Shares over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The chart presents the Earnings Per Share (EPS) performance of Abivax SA American Depositary Shares, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 100.0% positive surprise.

The Valuation section provides an overview of how Abivax SA American Depositary Shares is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.